133 related articles for article (PubMed ID: 28841582)
21. Pharmacy refill data can be used to predict virologic failure for patients on antiretroviral therapy in Brazil.
Martin D; Luz PM; Lake JE; Clark JL; Campos DP; Veloso VG; Moreira RI; Cardoso SW; Klausner JD; Grinsztejn B
J Int AIDS Soc; 2017 Jun; 20(1):21405. PubMed ID: 28605172
[TBL] [Abstract][Full Text] [Related]
22. Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12 years of observation.
Laprise C; de Pokomandy A; Baril JG; Dufresne S; Trottier H
Clin Infect Dis; 2013 Nov; 57(10):1489-96. PubMed ID: 23946221
[TBL] [Abstract][Full Text] [Related]
23. Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort.
Paris D; Ledergerber B; Weber R; Jost J; Flepp M; Opravil M; Ruef C; Zimmerli S
AIDS Res Hum Retroviruses; 1999 Dec; 15(18):1631-8. PubMed ID: 10606086
[TBL] [Abstract][Full Text] [Related]
24. Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda.
Spacek LA; Shihab HM; Kamya MR; Mwesigire D; Ronald A; Mayanja H; Moore RD; Bates M; Quinn TC
Clin Infect Dis; 2006 Jan; 42(2):252-9. PubMed ID: 16355337
[TBL] [Abstract][Full Text] [Related]
25. Treatment Failure in HIV-Infected Children on Second-line Protease Inhibitor-Based Antiretroviral Therapy.
Suaysod R; Ngo-Giang-Huong N; Salvadori N; Cressey TR; Kanjanavanit S; Techakunakorn P; Krikajornkitti S; Srirojana S; Laomanit L; Chalermpantmetagul S; Lallemant M; Le Cœur S; McIntosh K; Traisathit P; Jourdain G
Clin Infect Dis; 2015 Jul; 61(1):95-101. PubMed ID: 25838288
[TBL] [Abstract][Full Text] [Related]
26. Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009.
Hanna DB; Buchacz K; Gebo KA; Hessol NA; Horberg MA; Jacobson LP; Kirk GD; Kitahata MM; Korthuis PT; Moore RD; Napravnik S; Patel P; Silverberg MJ; Sterling TR; Willig JH; Lau B; Althoff KN; Crane HM; Collier AC; Samji H; Thorne JE; Gill MJ; Klein MB; Martin JN; Rodriguez B; Rourke SB; Gange SJ;
Clin Infect Dis; 2013 Apr; 56(8):1174-82. PubMed ID: 23315317
[TBL] [Abstract][Full Text] [Related]
27. Sustained Viral Suppression in HIV-infected Children on Once-daily Lopinavir/Ritonavir in Clinical Practice.
Gondrie IPE; Bastiaans DET; Fraaij PLA; Driessen GJA; van der Knaap LC; Visser EG; van Jaarsveld P; de Groot R; Hartwig NG; Burger DM; van Rossum AMC
Pediatr Infect Dis J; 2017 Oct; 36(10):976-980. PubMed ID: 28475554
[TBL] [Abstract][Full Text] [Related]
28. Comparison of developmental milestone attainment in early treated HIV-infected infants versus HIV-unexposed infants: a prospective cohort study.
Benki-Nugent S; Wamalwa D; Langat A; Tapia K; Adhiambo J; Chebet D; Okinyi HM; John-Stewart G
BMC Pediatr; 2017 Jan; 17(1):24. PubMed ID: 28095807
[TBL] [Abstract][Full Text] [Related]
29. Initial response to protease-inhibitor-based antiretroviral therapy among children less than 2 years of age in South Africa: effect of cotreatment for tuberculosis.
Reitz C; Coovadia A; Ko S; Meyers T; Strehlau R; Sherman G; Kuhn L; Abrams EJ
J Infect Dis; 2010 Apr; 201(8):1121-31. PubMed ID: 20214476
[TBL] [Abstract][Full Text] [Related]
30. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
[TBL] [Abstract][Full Text] [Related]
31. Viral load suppression in HIV-infected adolescents in cameroon: towards achieving the UNAIDS 95% viral suppression target.
Djiyou ABD; Penda CI; Madec Y; Ngondi GD; Moukoko A; Varloteaux M; de Monteynard LA; Moins C; Moukoko CEE; Aghokeng AF
BMC Pediatr; 2023 Mar; 23(1):119. PubMed ID: 36922769
[TBL] [Abstract][Full Text] [Related]
32. Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults.
Nachega JB; Hislop M; Dowdy DW; Gallant JE; Chaisson RE; Regensberg L; Maartens G
AIDS; 2008 Oct; 22(16):2117-25. PubMed ID: 18832875
[TBL] [Abstract][Full Text] [Related]
33. Early and Late Virologic Failure After Virologic Suppression in HIV-Infected Asian Children and Adolescents.
Mu W; Bartlett AW; Bunupuradah T; Chokephaibulkit K; Kumarasamy N; Ly PS; Hansudewechakul R; Nguyen LV; Lumbiganon P; Sudjaritruk T; Mohamed TAJ; Yusoff NKN; Truong KH; Do VC; Fong MS; Nallusamy R; Kurniati N; Wati DK; Sohn AH; Kariminia A; Zhang F;
J Acquir Immune Defic Syndr; 2019 Mar; 80(3):308-315. PubMed ID: 30531299
[TBL] [Abstract][Full Text] [Related]
34. Feasibility of Routinely Offering Early Combined Antiretroviral Therapy to HIV-infected Infants in a Resource-limited Country: The ANRS-PediaCAM Study in Cameroon.
Tejiokem MC; Warszawski J; Ateba Ndongo F; Tetang Ndiang S; Ndongo JA; Owona F; Ngoupo PA; Tchendjou P; Kfutwah A; Penda IC; Faye A
Pediatr Infect Dis J; 2015 Oct; 34(10):e248-53. PubMed ID: 26121199
[TBL] [Abstract][Full Text] [Related]
35. Increased Antiretroviral Therapy Use and Virologic Suppression in the Bronx in the Context of Multiple HIV Prevention Strategies.
Hanna DB; Felsen UR; Ginsberg MS; Zingman BS; Beil RS; Futterman DC; Strickler HD; Anastos K
AIDS Res Hum Retroviruses; 2016; 32(10-11):955-963. PubMed ID: 26892622
[TBL] [Abstract][Full Text] [Related]
36. Drug resistance among drug-naive and first-line antiretroviral treatment-failing children in Cameroon.
Fokam J; Salpini R; Santoro MM; Cento V; Perno CF; Colizzi V; Ndumbe PM; Fokunang Ntungen C; Ndiang Tetang SM; Nanfack AJ; Takou Komego DA; Cappelli G
Pediatr Infect Dis J; 2011 Dec; 30(12):1062-8. PubMed ID: 21817951
[TBL] [Abstract][Full Text] [Related]
37. Predictors of virologic failure in HIV-1-infected adults receiving first-line antiretroviral therapy in 8 provinces in China.
Ma Y; Zhao D; Yu L; Bulterys M; Robinson ML; Zhao Y; Dou Z; Chiliade P; Wei X; Zhang F
Clin Infect Dis; 2010 Jan; 50(2):264-71. PubMed ID: 20017637
[TBL] [Abstract][Full Text] [Related]
38. Viral Suppression in a Nationwide Sample of HIV-Infected Children on Antiretroviral Therapy in Rwanda.
Nsanzimana S; McArdle F; Remera E; Mulindabigwi A; Ribakare M; Ndimubanzi P; Kayirangwa E; Baribwira C; Riedel DJ; Ntaganira J
Pediatr Infect Dis J; 2019 Feb; 38(2):149-151. PubMed ID: 29794653
[TBL] [Abstract][Full Text] [Related]
39. A commitment contract to achieve virologic suppression in poorly adherent patients with HIV/AIDS.
Alsan M; Beshears J; Armstrong WS; Choi JJ; Madrian BC; Nguyen MLT; Del Rio C; Laibson D; Marconi VC
AIDS; 2017 Jul; 31(12):1765-1769. PubMed ID: 28514277
[TBL] [Abstract][Full Text] [Related]
40. Level of viral suppression and the cascade of HIV care in a South African semi-urban setting in 2012.
Jean K; Puren A; Cutler E; Singh B; Bouscaillou J; Rain-Taljaard R; Taljaard D; Gouws E; Lissouba P; Lewis DA; Peytavin G; Auvert B
AIDS; 2016 Aug; 30(13):2107-16. PubMed ID: 27163707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
